Determination of 4-methylpyrazole in plasma using solid phase extraction and HPLC.

Area of Science:

• Analytical Chemistry
• Biochemistry
• Pharmacology

Background:

• 4-methylpyrazole is a compound requiring precise quantification in biological matrices.
• Existing methods for 4-methylpyrazole determination may lack speed or sensitivity.
• Accurate measurement of 4-methylpyrazole is crucial for pharmacokinetic and toxicological studies.

Purpose of the Study:

• To develop and validate a rapid, sensitive, and precise method for determining 4-methylpyrazole concentrations in human plasma.
• To establish a reliable analytical technique for routine clinical or research use.

Main Methods:

• A rapid plasma sample preparation involving Solid Phase Extraction (SPE) using a BondElut SCX column.
• Analysis by isocratic reversed-phase high-performance liquid chromatography (RP-HPLC) with UV detection.
• Quantification using an internal standard (3-methylpyrazole) and peak height ratio calculation.

Main Results:

• The method demonstrated linearity over a concentration range of 2.5 to 100 µmol/L.
• High precision was achieved with within-day CV of 2.2% and day-to-day CV of 2.8%.
• Sufficient sensitivity for detecting 4-methylpyrazole in the low micromolar range of plasma samples.

Conclusions:

• The developed method is rapid, accurate, and precise for 4-methylpyrazole determination in plasma.
• This technique is suitable for analyzing plasma 4-methylpyrazole levels in various research and clinical settings.
• The method provides a valuable tool for pharmacokinetic studies and therapeutic drug monitoring.